PlainRecalls
FDA Drug Low Class III Terminated

Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44

Reported: May 3, 2023 Initiated: April 10, 2023 #D-0555-2023

Product Description

Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44

Reason for Recall

Subpotent Drug: Out of specification results for low potency was obtained.

Details

Recalling Firm
SCA Pharmaceuticals
Units Affected
73,312 containers
Distribution
Nationwide in the USA
Location
Windsor, CT

Frequently Asked Questions

What product was recalled?
Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44. Recalled by SCA Pharmaceuticals. Units affected: 73,312 containers.
Why was this product recalled?
Subpotent Drug: Out of specification results for low potency was obtained.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 3, 2023. Severity: Low. Recall number: D-0555-2023.